108 related articles for article (PubMed ID: 21525754)
1. Long-term, clinical follow-up in fatty liver patients.
Bendtsen F; Dam-Larsen S
Dig Dis; 2010; 28(6):709-14. PubMed ID: 21525754
[TBL] [Abstract][Full Text] [Related]
2. Final results of a long-term, clinical follow-up in fatty liver patients.
Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
[TBL] [Abstract][Full Text] [Related]
4. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.
Deleuran T; Grønbaek H; Vilstrup H; Jepsen P
Aliment Pharmacol Ther; 2012 Jun; 35(11):1336-42. PubMed ID: 22490057
[TBL] [Abstract][Full Text] [Related]
5. Histological characteristics and prognosis in patients with fatty liver.
Dam-Larsen S; Franzmann MB; Christoffersen P; Larsen K; Becker U; Bendtsen F
Scand J Gastroenterol; 2005 Apr; 40(4):460-7. PubMed ID: 16028442
[TBL] [Abstract][Full Text] [Related]
6. Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.
Semb S; Neermark S; Dam-Larsen S; Franzmann MB; Albrectsen J; Kallemose T; Becker U; Bendtsen F
Scand J Gastroenterol; 2016 Nov; 51(11):1367-74. PubMed ID: 27381376
[TBL] [Abstract][Full Text] [Related]
7. Long term prognosis of fatty liver: risk of chronic liver disease and death.
Dam-Larsen S; Franzmann M; Andersen IB; Christoffersen P; Jensen LB; Sørensen TI; Becker U; Bendtsen F
Gut; 2004 May; 53(5):750-5. PubMed ID: 15082596
[TBL] [Abstract][Full Text] [Related]
8. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with nonalcoholic fatty liver.
Rafiq N; Bai C; Fang Y; Srishord M; McCullough A; Gramlich T; Younossi ZM
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):234-8. PubMed ID: 19049831
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD.
Önnerhag K; Nilsson PM; Lindgren S
Scand J Gastroenterol; 2014 Sep; 49(9):1111-8. PubMed ID: 24990583
[TBL] [Abstract][Full Text] [Related]
11. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver and mortality: a cohort population study in South Italy.
Caruso MG; Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Donghia R; Logroscino A; Rotolo O; Chiloiro M; Leandro G; De Leonardis G; Tutino V; Misciagna G; Bonfiglio C; Guerra R; Osella A
BMJ Open; 2019 Jun; 9(6):e027379. PubMed ID: 31227533
[TBL] [Abstract][Full Text] [Related]
13. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
McPherson S; Hardy T; Henderson E; Burt AD; Day CP; Anstee QM
J Hepatol; 2015 May; 62(5):1148-55. PubMed ID: 25477264
[TBL] [Abstract][Full Text] [Related]
14. Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease.
Sookoian S; Pirola CJ
PLoS One; 2013; 8(3):e58895. PubMed ID: 23516571
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
[TBL] [Abstract][Full Text] [Related]
16. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.
Kanwal F; Kramer JR; Mapakshi S; Natarajan Y; Chayanupatkul M; Richardson PA; Li L; Desiderio R; Thrift AP; Asch SM; Chu J; El-Serag HB
Gastroenterology; 2018 Dec; 155(6):1828-1837.e2. PubMed ID: 30144434
[TBL] [Abstract][Full Text] [Related]
17. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease.
Mills SJ; Harrison SA
Curr Gastroenterol Rep; 2005 Feb; 7(1):32-6. PubMed ID: 15701296
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease.
Yu CW; Chen CH; Cheng YC; Hsieh WC; Hsu TJ; Tsai FJ; Hsu CY
Eur J Med Res; 2023 Dec; 28(1):550. PubMed ID: 38042817
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors in non-alcoholic fatty liver disease.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Askling J; Hultcrantz R; Kechagias S
Liver Int; 2019 Jan; 39(1):197-204. PubMed ID: 30253056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
